drugset / Trial / NCT00000534

Calcium for Pre-Eclampsia Prevention (CPEP)

NCT00000534

Double-blindPrevention

Summary

To evaluate the efficacy of 2 grams per day of oral calcium supplementation in reducing the combined incidence of hypertensive disorders of pregnancy: pre-eclampsia, eclampsia, and the HELLP Syndrome (hypertension, thrombocytopenia, hemolysis, and abnormal liver function). The National Institute of Child Health and Human Development (NICHD) initiated the trial in 1991, with joint funding provided by the National Heart, Lung, and Blood Institute in fiscal years 1992, 1993, and 1995.

Timeline

Start
1991-03
Primary completion
Completion
2000-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcium carbonate Other / unclassified 2 g Oral